These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8782879)

  • 21. Interaction between cAMP elevation, identified growth factors, and serum components in regulating Schwann cell growth.
    Stewart HJ; Eccleston PA; Jessen KR; Mirsky R
    J Neurosci Res; 1991 Oct; 30(2):346-52. PubMed ID: 1665868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of steroidogenic acute regulatory protein in cultured Schwann cells and its regulation by cAMP.
    Benmessahel Y; Guennoun R; Cadepond F; Baulieu EE; Schumacher M; Groyer G
    Ann N Y Acad Sci; 2002 Nov; 973():83-7. PubMed ID: 12485839
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gangliosides modulate Schwann cell proliferation and morphology.
    Sobue G; Taki T; Yasuda T; Mitsuma T
    Brain Res; 1988 Dec; 474(2):287-95. PubMed ID: 2850090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tissue culture studies of Schwann cell proliferation and differentiation.
    Pleasure D; Kreider B; Shuman S; Sobue G
    Dev Neurosci; 1985; 7(5-6):364-73. PubMed ID: 2424706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of c-Jun, Jun B, Jun D and cAMP response element binding protein by Schwann cells and their precursors in vivo and in vitro.
    Stewart HJ
    Eur J Neurosci; 1995 Jun; 7(6):1366-75. PubMed ID: 7582111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased cyclic AMP in in vitro regenerating frog sciatic nerves inhibits Schwann cell proliferation but has no effect on axonal outgrowth.
    Ekström PA
    J Neurosci Res; 1995 Sep; 42(1):54-62. PubMed ID: 8531226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 04 and A007-sulfatide antibodies bind to embryonic Schwann cells prior to the appearance of galactocerebroside; regulation of the antigen by axon-Schwann cell signals and cyclic AMP.
    Mirsky R; Dubois C; Morgan L; Jessen KR
    Development; 1990 May; 109(1):105-16. PubMed ID: 2170096
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Schwann cells depleted of galactocerebroside express myelin-associated glycoprotein and initiate but do not continue the process of myelination.
    Owens GC; Bunge RP
    Glia; 1990; 3(2):118-24. PubMed ID: 1692007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of Schwann cell nerve growth factor receptor by cyclic adenosine 3',5'-monophosphate.
    Mokuno K; Sobue G; Reddy UR; Wurzer J; Kreider B; Hotta H; Baron P; Ross AH; Pleasure D
    J Neurosci Res; 1988; 21(2-4):465-72. PubMed ID: 2851058
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin-like growth factor I: a mitogen for rat Schwann cells in the presence of elevated levels of cyclic AMP.
    Schumacher M; Jung-Testas I; Robel P; Baulieu EE
    Glia; 1993 Aug; 8(4):232-40. PubMed ID: 8406680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. cAMP-dependent reorganization of the Cajal bodies and splicing machinery in cultured Schwann cells.
    Fernandez R; Pena E; Navascues J; Casafont I; Lafarga M; Berciano MT
    Glia; 2002 Dec; 40(3):378-88. PubMed ID: 12420317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence for an early role for myelin-associated glycoprotein in the process of myelination.
    Owens GC; Bunge RP
    Glia; 1989; 2(2):119-28. PubMed ID: 2470674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Variable galactocerebroside expression by human Schwann cells in dissociated and peripheral nerve explant cultures.
    Turnbull VJ; Petratos S; Papadopoulos R; Gonzales MF; Ayers M
    J Neurosci Res; 2001 Aug; 65(4):318-21. PubMed ID: 11494367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estrogen and progesterone stimulate Schwann cell proliferation in a sex- and age-dependent manner.
    Fex Svenningsen A; Kanje M
    J Neurosci Res; 1999 Jul; 57(1):124-30. PubMed ID: 10397642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Age-related differences in proliferative responses of Schwann cells during Wallerian degeneration.
    Komiyama A; Suzuki K
    Brain Res; 1992 Feb; 573(2):267-75. PubMed ID: 1380391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Experimental lead neuropathy: inorganic lead inhibits proliferation but not differentiation of Schwann cells.
    Sobue G; Pleasure D
    Ann Neurol; 1985 May; 17(5):462-8. PubMed ID: 2988413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of cyclic AMP on expression of myelin genes in the N20.1 oligodendroglial cell line.
    Studzinski DM; Ramaswamy R; Benjamins JA
    Neurochem Res; 1998 Mar; 23(3):435-41. PubMed ID: 9482258
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transforming growth factors-beta 1 and beta 2 are mitogens for rat Schwann cells.
    Ridley AJ; Davis JB; Stroobant P; Land H
    J Cell Biol; 1989 Dec; 109(6 Pt 2):3419-24. PubMed ID: 2557356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inflammatory cytokines inhibit upregulation of glycolipid expression by Schwann cells in vitro.
    Lisak RP; Bealmear B; Benjamins J; Skoff A
    Neurology; 1998 Dec; 51(6):1661-5. PubMed ID: 9855519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum and forskolin cooperate to promote G1 progression in Schwann cells by differentially regulating cyclin D1, cyclin E1, and p27Kip expression.
    Iacovelli J; Lopera J; Bott M; Baldwin E; Khaled A; Uddin N; Fernandez-Valle C
    Glia; 2007 Dec; 55(16):1638-47. PubMed ID: 17849471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.